On ECHEMI
Home > Drugs > Congenital pure red cell aplasia
Congenital pure red cell aplasia
Congenital pure red cell aplasia, also known as Diamond-Blackfan anemia (DBA), is a rare congenital pure red cell aplasia with anemia as the main clinical manifestation and involvement of multiple system tissues as the main clinical feature of the disease.
  • Site of disease:

    Blood vessels
  • Infectious :

    Not contagious
  • Frequent population:

    Infants and children
  • Related symptoms:

    Dizziness fatigue palpitations shortness of breath shortness of breath
  • Concurrent disease:

Related Drugs
Mannan peptide tablets
Indication: Used as an adjuvant treatment for immunosuppression, recurrent respiratory tract infections, leukopenia, aplastic anemia and tumor treatment, and to reduce the side effects of radiotherapy and chemotherapy on the hematopoietic system and gastrointestinal reactions.
Manufacturer:

Zhejiang Sukean Pharmaceutical Co., Ltd.

Mannan peptide tablets
Indication: Used as an adjuvant treatment for immunosuppression, recurrent respiratory tract infections, leukopenia, aplastic anemia and tumor treatment, and to reduce the side effects of radiotherapy and chemotherapy on the hematopoietic system and gastrointestinal reactions.
Manufacturer:

Chengdu Leer Pharmaceutical Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.